Recurrence of precancerous colorectal tumors a greater risk for sedentary men
10/31/2013
Men who spend the most time engaged in sedentary behaviors are at greatest risk for recurrence of colorectal adenomas, benign tumors that are known precursors of colorectal cancers, according to results presented at the 12th Annual AACR International Conference on Frontiers in Cancer Prevention Research...
Unique nano carrier developed to target drug delivery to cancer cells
10/31/2013
A unique nanostructure developed by a team of international researchers, including those at the University of Cincinnati, promises improved all-in-one detection, diagnoses and drug-delivery treatment of cancer cells. The first-of-its-kind nanostructure is unusual because it can carry a variety of cancer-fighting materials on its double-sided (Janus) surface and within its porous interior...
Fresh blood 'may be better for patients'
10/31/2013
If you need a blood transfusion, the last thing you need to worry about is the age of the donated blood. Researchers from the Cleveland Clinic in Ohio say that adopting modern inventory management strategies could greatly reduce blood storage time and potentially reduce the risk of complications for the patient...
Zebrafish may predict therapy response to prostate cancer
10/30/2013
Researchers have investigated the use of zebrafish to identify self-renewing tumor stem cells in prostate cancer, and they say the model could be more beneficial for predicting therapy response, compared with traditional experimental models. According to the American Cancer Society, prostate cancer - cancer of the prostate gland - is the second most common cancer in American men...
Zebrafish may predict therapy response to prostate cancer
10/30/2013
Researchers have investigated the use of zebrafish to identify self-renewing tumor stem cells in prostate cancer, and they say the model could be more beneficial for predicting therapy response, compared with traditional experimental models. According to the American Cancer Society, prostate cancer - cancer of the prostate gland - is the second most common cancer in American men...
Foundation Medicine identifies novel, clinically actionable gene fusion NTRK1 in lung cancer
10/30/2013
Foundation Medicine, Inc. (NASDAQ:FMI) has announced that the discovery of a novel and potentially clinically actionable oncogenic gene fusion in lung cancer, NTRK1, using FoundationOneTM, was published in the current online edition of Nature Medicine1...
Five commonly performed tests and treatments in pulmonary medicine may not always be necessary
10/30/2013
A list released on October 28th, identified five commonly performed tests and procedures in pulmonary medicine that may not always be necessary. The list, part of the ABIM Foundation's Choosing Wisely® campaign, was produced by a collaborative task force assembled by the American Thoracic Society (ATS) and the American College of Chest Physicians (ACCP)...
Preliminary results find African-American women disadvantaged when it comes to HPV vaccines
10/30/2013
Two subtypes of human papillomavirus (HPV) prevented by vaccines are half as likely to be found in African-American women as in white women with precancerous cervical lesions, according to researchers at Duke Medicine...
After thyroid cancer, measuring segments of genetic material may help predict and monitor recurrence
10/30/2013
A new analysis has found that the presence of short segments of genetic material (known as microRNA) within papillary thyroid cancer tumors suggests a likelihood of recurrence after patients undergo surgery...
Lipid secreted by tumors acts like 'invisibility cloak'
10/30/2013
Researchers at National Jewish Health have discovered how a lipid secreted by cancer tumors prevents the immune system from mounting an immune response against it. When lysophosphatidic acid (LPA) binds to killer T cells, it acts almost like an "invisibility cloak," preventing T cells from recognizing and attacking nascent tumors...